Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALLO Allogene Therapeutics Inc.

休市中 11-22 16:00:00 EST

2.21

+0.10

+4.74%

盘后2.30

+0.09+4.07%

19:59 EST

最高2.23	最低2.09	成交量145.68万
今开2.12	昨收2.11	日振幅6.64%
总市值4.63亿	流通市值3.36亿	总股本2.10亿
成交额317.58万	换手率0.96%	流通股本1.52亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALLO","market":"US","secType":"STK","nameCN":"Allogene Therapeutics Inc.","latestPrice":2.21,"timestamp":1732309200000,"preClose":2.11,"halted":0,"volume":1456823,"hourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.21,"latestTime":"19:59 EST","volume":46600,"amount":105230.3098,"timestamp":1732323580263},"delay":0,"floatShares":151870632,"shares":209672091,"eps":-1.538233,"marketStatus":"休市中","marketStatusCode":7,"change":0.1,"latestTime":"11-22 16:00:00 EST","open":2.12,"high":2.23,"low":2.09,"amount":3175792.9949589,"amplitude":0.066351,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.538233,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1539230400000,"adjPreClose":2.11,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.12,"preClose":2.11,"latestTime":"09:29 EST","volume":9105,"amount":19485.4329525,"timestamp":1732285799912},"postHourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.21,"latestTime":"19:59 EST","volume":46600,"amount":105230.3098,"timestamp":1732323580263},"volumeRatio":0.5529766245254993,"impliedVol":0.1249,"impliedVolPercentile":0.0397},"requestUrl":"/m/hq/s/ALLO/wiki","defaultTab":"wiki","newsList":[{"id":"2485291317","title":"Allogene Therapeutics, Inc.盘中异动 大幅上涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485291317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485291317?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:11","pubTimestamp":1732295495,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时11分，Allogene Therapeutics, Inc.股票出现异动，股价快速上涨5.69%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301113598e4434c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301113598e4434c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","BK4139","BK4505","LENZ"],"gpt_icon":0},{"id":"2485126101","title":"Allogene Therapeutics, Inc.盘中异动 快速下挫5.13%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485126101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485126101?lang=zh_cn&edition=full","pubTime":"2024-11-21 02:06","pubTimestamp":1732126013,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日02时06分，Allogene Therapeutics, Inc.股票出现波动，股价快速下跌5.13%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121020653971a7bd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121020653971a7bd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","BK4139","ALLO"],"gpt_icon":0},{"id":"2484560466","title":"Allogene Therapeutics, Inc.盘中异动 下午盘急速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484560466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484560466?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:16","pubTimestamp":1731953788,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时16分，Allogene Therapeutics, Inc.股票出现异动，股价急速下跌5.07%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119021628971a73f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119021628971a73f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLO","BK4505","LENZ"],"gpt_icon":0},{"id":"2484543695","title":"Allogene Therapeutics, Inc.2024财年第三财季实现净利润-66.29百万美元，同比减少8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484543695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484543695?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731772984,"startTime":"0","endTime":"0","summary":"11月17日，Allogene Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-66.29百万美元，同比减少8.11%；其中营业收入为0.00美元，每股基本收益为-0.32美元。从资产负债表来看，Allogene Therapeutics, Inc.总负债1.25亿美元，其中短期债务7.39百万美元，资产负债比为4.72，流动比率为0.10。机构评级：截至2024年11月17日，当前有14家机构对Allogene Therapeutics, Inc.目标价做出预测，其中目标均价为9.64美元，其中最低目标价为3.50美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000401a23e06bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000401a23e06bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLO"],"gpt_icon":0},{"id":"2483802270","title":"Allogene Therapeutics, Inc.盘中异动 早盘大幅下挫6.25%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483802270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483802270?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:55","pubTimestamp":1731596150,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时55分，Allogene Therapeutics, Inc.股票出现异动，股价快速下挫6.25%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422555098e42a9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422555098e42a9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4505","ALLO"],"gpt_icon":0},{"id":"2483050876","title":"美国研究综述-思科、Freshpet、Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050876","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483050876?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:06","pubTimestamp":1731585982,"startTime":"0","endTime":"0","summary":"美国研究综述-思科、Freshpet、Nvidia路透11月14日 - 华尔街证券分析师周四调整了对思科、Freshpet 和 Nvidia 等几家美国上市公司的评级和目标价。要闻 * 思科CSCO.O：杰富瑞将目标价从53美元上调至66美元 * Freshpet Inc FRPT.O：奥本海默将目标价从155美元上调至180美元  * ICU Medical Inc ICUI.O：Raymond James将目标价从190美元上调至205美元  * Kronos Bio Inc KRON.O：TD Cowen将目标价从买入下调至持有 * Nvidia Corp NVDA.O：奥本海默将目标价从 150 美元上调至 175 美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML18A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHX","IE00BFXG1179.USD","BK4209","BTMD","APEI","ALSN","AZTA","SLRN","FDMT","CTRA","CNNE","AIT","LU0234572021.USD","ACRV","BPMC","CAKE","COGT","CBSH","CPB","CPAY","SG9999002232.USD","IE00BZ1G4Q59.USD","ALMS","CRVS","CSCO","AMGN","LU1244550494.USD","BIIB","ADAP","BKR","LU0868494708.USD","BWXT","AXTA","LU1244550577.SGD","CHGG","CAVA","ALLO","AROC","AVB","CPT","APD","LU0300736492.USD","LU1894683348.USD","BK4550","LU2106854487.HKD","SPRY","EE","AESI","DOX","BRBR"],"gpt_icon":0},{"id":"2483384830","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483384830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483384830?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:22","pubTimestamp":1731428533,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日00时22分，Allogene Therapeutics, Inc.股票出现异动，股价快速下跌5.02%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111300221398e42217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111300221398e42217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLO","BK4139","BK4505"],"gpt_icon":0},{"id":"2482364437","title":"美国研究综述-Bath & Body Works、Datadog、Savers Value Village","url":"https://stock-news.laohu8.com/highlight/detail?id=2482364437","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482364437?lang=zh_cn&edition=full","pubTime":"2024-11-09 03:57","pubTimestamp":1731095879,"startTime":"0","endTime":"0","summary":"美国研究综述-Bath & Body Works、Datadog、Savers Value Village路透11月8日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Bath & Body Works、Datadog 和 Savers Value Village。要点 * Bath & Body Works Inc BBWI.N：巴克莱将其股票评级从等权下调至减持 * Datadog Inc DDOG.O：Monness Crespi Hardt将其评级从中性上调至买入  * Montrose Environmental Group Inc MEG.N：摩根大通将其评级从 \"增持 \"下调至 \"中性  * Savers Value Village Inc SVV.N：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF2ER:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACIW","ACLX","ADMA","ALLO","APPN","BK4023","IE00B894F039.SGD","ABNB","AFRM","BK4157","AMRC","AEE","APA","IE00B66KJ199.SGD","SVV","AGL","AMPL","ACRE","APLE","DDOG","AMN","ASTH","ARLO","BK4196","ALRM","AKA","ACVA","ALB","ANET","ASLE","AMH","ARHS","ACMR","ARRY","BK4094","AIZ","LU0240878834.USD","ATEN","ARQT","BK4116","GOLF","AMLX","ACHR","APD","APP","AWR","IE00B7SZL793.SGD","AKAM","AORT","BK4528"],"gpt_icon":1},{"id":"1114774726","title":"异动解读 | Allogene Therapeutics Inc财报不达预期 股价盘中大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114774726","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114774726?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:35","pubTimestamp":1731076545,"startTime":"0","endTime":"0","summary":"生物技术公司Allogene Therapeutics Inc今日股价盘中大跌5.33%,引发市场广泛关注。公司最新公布的2024年第三季度财报显示,公司在业绩和收入方面均未能达到分析师预期,这被认为是导致股价下跌的主要原因。具体来看,Allogene Therapeutics Inc本季度调整后每股亏损达32美分,高于分析师预期的33美分亏损。分析人士认为,近期连续的业绩不佳加上收入预期的失利,令投资者对Allogene Therapeutics Inc的发展前景失去信心,从而引发了当日盘中股价的大幅下跌。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ALLO"],"gpt_icon":0},{"id":"2481110260","title":"Allogene Therapeutics, Inc.盘中异动 早盘快速下跌5.33%报3.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481110260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481110260?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076365,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分，Allogene Therapeutics, Inc.股票出现波动，股价快速跳水5.33%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324598e41783&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324598e41783&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","ALLO"],"gpt_icon":0},{"id":"2481287118","title":"阿洛金治疗公司公布截至 1 月 1 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481287118","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481287118?lang=zh_cn&edition=full","pubTime":"2024-11-08 13:16","pubTimestamp":1731043007,"startTime":"0","endTime":"0","summary":"   * Allogene Therapeutics Inc   报告，截至1月1日的季度调整后每股亏损32美分，高于去年同期的每股-37美分。17位分析师对该季度的平均预期是每股亏损33美分。华尔街预期为每股-39美分至-29美分。* Allogene Therapeutics Inc报告的本季度每股收益为亏损32美分。* 该公司当季亏损 6629 万美元。* 本季度，Allogene Therapeutics Inc 的股价上涨了 13.9%，今年迄今为止亏损了 0.6%。华尔街对 Allogene Therapeutics Inc 的 12 个月目标价中位数为 9.50 美元。本摘要由 LSEG 数据于 11 月 8 日 05:16 a.m. UTC 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"阿洛金治疗公司公布截至 1 月 1 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","ALLO"],"gpt_icon":0},{"id":"2481639983","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.02%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481639983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481639983?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903495,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Allogene Therapeutics, Inc.股票出现波动，股价急速上涨5.02%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223136aba6afb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223136aba6afb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4505","ALLO"],"gpt_icon":0},{"id":"2481611845","title":"Allogene Therapeutics Inc    预计每股亏损 33 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481611845","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481611845?lang=zh_cn&edition=full","pubTime":"2024-11-06 12:36","pubTimestamp":1730867775,"startTime":"0","endTime":"0","summary":"   * Allogene Therapeutics Inc    将于11月7日公布截至2024年9月30日的季度业绩报告，预计该公司的季度收入将出现下降。* LSEG 分析师对 Allogene Therapeutics Inc 的平均预期是每股亏损 33 美分。* 华尔街对 Allogene Therapeutics Inc 的 12 个月目标价中位数为 9.50 美元，高于 2.99 美元的最新收盘价。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLO","LENZ"],"gpt_icon":0},{"id":"2480058782","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报2.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058782?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:05","pubTimestamp":1730732747,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时05分，Allogene Therapeutics, Inc.股票出现波动，股价急速上涨5.15%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230548971a42f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230548971a42f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2480819478","title":"Allogene Therapeutics, Inc.盘中异动 早盘大幅拉升5.09%报2.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480819478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480819478?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:52","pubTimestamp":1730469161,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时52分，Allogene Therapeutics, Inc.股票出现异动，股价急速上涨5.09%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121524198e40035&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121524198e40035&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2479786525","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479786525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479786525?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:55","pubTimestamp":1730296503,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时55分，Allogene Therapeutics, Inc.股票出现异动，股价急速上涨5.54%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030215503a1faecd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030215503a1faecd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","ALLO"],"gpt_icon":0},{"id":"2479288441","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.22%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479288441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479288441?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:31","pubTimestamp":1730208668,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时31分，Allogene Therapeutics, Inc.股票出现波动，股价大幅上涨5.22%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213108a1f59efc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213108a1f59efc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","ALLO","BK4139"],"gpt_icon":0},{"id":"2478481386","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.33%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478481386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478481386?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:43","pubTimestamp":1730123002,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时43分，Allogene Therapeutics, Inc.股票出现波动，股价快速上涨5.33%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214322ab7bca8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214322ab7bca8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4505","ALLO"],"gpt_icon":0},{"id":"2477630013","title":"Allogene Therapeutics, Inc.盘中异动 早盘急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477630013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477630013?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:35","pubTimestamp":1729780519,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时35分，Allogene Therapeutics, Inc.股票出现异动，股价大幅下挫5.05%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422351998e3e46c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422351998e3e46c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2476293393","title":"Allogene Therapeutics, Inc.盘中异动 下午盘快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476293393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476293393?lang=zh_cn&edition=full","pubTime":"2024-10-19 01:15","pubTimestamp":1729271721,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日01时15分，Allogene Therapeutics, Inc.股票出现异动，股价大幅拉升5.02%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019011521ab6b35a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019011521ab6b35a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","ALLO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allogene.com","stockEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":-0.2022},{"period":"3month","weight":-0.1533},{"period":"6month","weight":-0.123},{"period":"1year","weight":-0.1875},{"period":"ytd","weight":-0.3115}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Allogene Therapeutics, Inc.于2017年11月30日在特拉华州成立，总部位于加利福尼亚州南旧金山。该公司是一家临床阶段免疫肿瘤学公司，开创了用于治疗癌症的基因工程异体T细胞疗法的开发和商业化。公司正在开发一种现成的T细胞候选产品系列，旨在靶向和杀死癌细胞。Allogene Therapeutics, Inc.工程改造的T细胞是同种异体的，这意味着它们来自健康供体，用于任何患者，而不是来自患者的个体患者，如自体T细胞的情况。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.071404},{"month":2,"riseRate":0.666667,"avgChangeRate":0.050796},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.111126},{"month":4,"riseRate":0.5,"avgChangeRate":0.005289},{"month":5,"riseRate":0.166667,"avgChangeRate":0.032626},{"month":6,"riseRate":0.5,"avgChangeRate":0.040631},{"month":7,"riseRate":0.5,"avgChangeRate":0.041827},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.054633},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.032739},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.102868},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.010751},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.098907}],"exchange":"NASDAQ","name":"Allogene Therapeutics Inc.","nameEN":"Allogene Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Allogene Therapeutics Inc.,ALLO,Allogene Therapeutics Inc.股票,Allogene Therapeutics Inc.股票老虎,Allogene Therapeutics Inc.股票老虎国际,Allogene Therapeutics Inc.行情,Allogene Therapeutics Inc.股票行情,Allogene Therapeutics Inc.股价,Allogene Therapeutics Inc.股市,Allogene Therapeutics Inc.股票价格,Allogene Therapeutics Inc.股票交易,Allogene Therapeutics Inc.股票购买,Allogene Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}